Literature DB >> 15389753

Brain perfusion and dopaminergic genes in boys with attention-deficit/hyperactivity disorder.

Claudia Szobot1, Tatiana Roman, Renato Cunha, Paul Acton, Mara Hutz, Luis Augusto Rohde.   

Abstract

Neuroimaging studies have suggested the involvement of several brain areas in attention-deficit/hyperactivity disorder (ADHD). Genetic investigations have supported the role of both dopamine D4 receptor gene (DRD4) and dopamine transporter gene (DAT1) in the vulnerability to the disorder. This study evaluates whether the presence of risk alleles at DRD4 and/or DAT1 genes is associated with differences in regional cerebral blood flow (rCBF) in a sample of ADHD boys. The rCBF was compared between ADHD patients with and without risk alleles at DRD4 (7-repeat allele) and/or at DAT1 (homozygosis for the 10-repeat allele) genes by single photon emission computed tomography (SPECT) during continuous performance test. Images were analyzed using statistical parametric mapping (SPM-99). No significant differences in rCBF were found both between ADHD boys with and without the 7-repeat allele at DRD4 locus, as well as between ADHD boys homozygous for the 10-repeat allele and ADHD subjects with other genotypes at the DAT1 locus. However, a significantly higher perfusion in the right middle temporal gyrus was found in the group with risk alleles at both DRD4 and DAT1 loci (n = 6) compared to ADHD boys without risk alleles at both loci (n = 28) (P < 0.05). Our findings suggest that a higher recruitment in middle temporal gyrus, an area associated to working memory and selective attention, should exist to compensate a putative effect of the interaction between these dopaminergic genes. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15389753     DOI: 10.1002/ajmg.b.30096

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  7 in total

1.  Regional differences in cerebral perfusion associated with the alpha-2A-adrenergic receptor genotypes in attention deficit hyperactivity disorder.

Authors:  Boong-Nyun Kim; Jae-Won Kim; Hyejin Kang; Soo-Churl Cho; Min-Sup Shin; Hee-Jeong Yoo; Soon-Beom Hong; Dong Soo Lee
Journal:  J Psychiatry Neurosci       Date:  2010-09       Impact factor: 6.186

Review 2.  Low dopamine function in attention deficit/hyperactivity disorder: should genotyping signify early diagnosis in children?

Authors:  Mark S Gold; Kenneth Blum; Marlene Oscar-Berman; Eric R Braverman
Journal:  Postgrad Med       Date:  2014-01       Impact factor: 3.840

3.  Dopamine transporter gene variation modulates activation of striatum in youth with ADHD.

Authors:  Anne-Claude Bédard; Kurt P Schulz; Edwin H Cook; Jin Fan; Suzanne M Clerkin; Iliyan Ivanov; Jeffrey M Halperin; Jeffrey H Newcorn
Journal:  Neuroimage       Date:  2009-12-21       Impact factor: 6.556

4.  Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation.

Authors:  Sean P David; Richard A Brown; George D Papandonatos; Christopher W Kahler; Elizabeth E Lloyd-Richardson; Marcus R Munafò; Peter G Shields; Caryn Lerman; David Strong; Jeanne McCaffery; Raymond Niaura
Journal:  Nicotine Tob Res       Date:  2007-08       Impact factor: 4.244

5.  Influence of SLC6A3 and COMT variation on neural activation during response inhibition.

Authors:  Eliza Congdon; R Todd Constable; Klaus Peter Lesch; Turhan Canli
Journal:  Biol Psychol       Date:  2009-03-28       Impact factor: 3.251

Review 6.  A neurogenetic approach to impulsivity.

Authors:  Eliza Congdon; Turhan Canli
Journal:  J Pers       Date:  2008-12

7.  The Brazilian contribution to Attention-Deficit/Hyperactivity Disorder molecular genetics in children and adolescents.

Authors:  Júlia Pasqualini Genro; Tatiana Roman; Luis Augusto Rohde; Mara Helena Hutz
Journal:  Genet Mol Biol       Date:  2012-12-18       Impact factor: 1.771

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.